Christian Kersten

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

Paal Brunsvig, Jon Amund Kyte, Christian Kersten et al. · Clinical Cancer Research · 2011 · 156 citations

Medicine, Immunology, Oncology +16

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer

Bjørn Naume, Marit Synnestvedt, Ragnhild Sørum Falk et al. · Journal of Clinical Oncology · 2014 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Maria Thomsen, Christian Kersten, Halfdan Sørbye et al. · Oncotarget · 2016 · 80 citations · Full text

Medicine, Immunology, Oncology +17